Synthego has applied our expertise in CRISPR genome editing to produce gRNAs specific for your IND-enabling studies in preparation for your IND submission. In this flyer, learn more about our IND-enabling (INDe) sgRNAs including the process, documentation, and dedicated facility that can help you achieve IND success.

Synthego can help you transition from discovery research through process development into the clinic with our continuum sgRNA available in different grades. With our comprehensive range of sgRNA quality options - large-scale RUO, INDe, and GMP - we are poised to help guide your CRISPR-based therapeutic development successfully from Discovery to Delivery.

In this flyer, learn how Synthego’s INDe sgRNAs can help you successfully navigate CRISPR-based therapeutic development and prepare you for a successful IND submission, including:

  • Details for manufacturing and quality of our INDe sgRNAs
  • Breakdown of the steps in an INDe sgRNA project
  • Our dedicated facility resources for INDes sgRNAs

Download the INDe sgRNA Manufacturing flyer now!